Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fulcrum Therapeutics

Clinical trials sponsored by Fulcrum Therapeutics, explained in plain language.

Fulcrum Therapeutics FULC NASDAQ

A clinical-stage biopharmaceutical company developing small molecules for genetic diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1 Terminated 4

New sickle cell drug shows promise in early safety trial

Disease control Completed

This early-stage study tested a new drug, Pociredir (FTX-6058), in 45 adults with sickle cell disease to see if it is safe and how the body processes it. The main goal was to check for side effects and measure drug levels in the blood. Researchers also looked at changes in fetal …

Phase: PHASE1 • Sponsor: Fulcrum Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC